InvestorsHub Logo

Blue Fin

01/14/18 7:01 PM

#212835 RE: DaubersUP #212831

Great post D. U. worth a sticky.


Profile Your Partner
Often it’s beneficial to get the partner to sell you on why they would make a good partner. Ask them for a capabilities presentation. Ask them how they’re going to maximize the value of your asset. Understand their pipeline and how your asset will fit into it. For example, if you have an asset that has multiple indications, it’s very important to have a discussion about how they’re going to develop multiple indications. Do they see the priority the same way you do?

LilyGDog

01/15/18 4:24 PM

#212921 RE: DaubersUP #212831

Thank you, I learned a lot.

Go Leo & IPIX!

Great weekend re-read:
c.ymcdn.com/sites/www.bioflorida.com/resource/resmgr/imported/ShareVault%20whitepaper%20-%20Getting%20Ready%20for%20BioPharma%20Partnering%20v2.pdf


Remember Leo confirmed they have had a great virtual room with cable!


Our time is near friends. IMO.

DaubersUP

01/29/18 9:32 AM

#214565 RE: DaubersUP #212831

“A typical large pharmaceutical might see 500 to 1,000 opportunities in a given therapeutic area. Only 100 or so of those will go on to non-con dential meetings and only 50 or so of those will end up going to Con dential Disclosure Agreements (CDAs) and con dential meetings.”